Myriam Chalabi
- Oncology top 5%
- Surgery
- Pathology and Forensic Medicine top 10%
- Pulmonary and Respiratory Medicine top 10%
- Immunology
- Co-authors
- Marleen KokMonique E. van LeerdamAndrés F. CardonaDeepti R. NagarkarFernanda HerreraAchim RittmeyerArianna ScalaMatthew L. Albert
- Topics
- Cancer Immunotherapy and Biomarkers (23 papers)Colorectal Cancer Treatments and Studies (17 papers)Genetic factors in colorectal cancer (13 papers)
- Partner nations
- NetherlandsUnited StatesBelgium
In The Last Decade
Myriam Chalabi
36 papers receiving 864 citations
Hit Papers
Peers
Comparison fields: 5 of 64
- Oncology 695
- Surgery 233
- Pathology and Forensic Medicine 217
- Pulmonary and Respiratory Medicine 216
- Immunology 120
Countries citing papers authored by Myriam Chalabi
This map shows the geographic impact of Myriam Chalabi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Myriam Chalabi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Myriam Chalabi more than expected).
Fields of papers citing papers by Myriam Chalabi
This network shows the impact of papers produced by Myriam Chalabi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Myriam Chalabi. The network helps show where Myriam Chalabi may publish in the future.
Co-authorship network of co-authors of Myriam Chalabi
This figure shows the co-authorship network connecting the top 25 collaborators of Myriam Chalabi. A scholar is included among the top collaborators of Myriam Chalabi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Myriam Chalabi. Myriam Chalabi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | Management of Locally Advanced Rectal Cancer: ASCO Guidelinebreakdown → | 47 |
| 3 | 5 | |
| 4 | Neoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer: a phase 2 trialbreakdown → | 40 |
| 5 | 1 | |
| 6 | 4 | |
| 7 | 0 | |
| 8 | 8 | |
| 9 | 16 | |
| 10 | 6 | |
| 11 | 3 | |
| 12 | LBA7 Neoadjuvant immune checkpoint inhibition in locally advanced MMR-deficient colon cancer: The NICHE-2 studybreakdown → | 129 |
| 13 | 3 | |
| 14 | 7 | |
| 15 | 201 | |
| 16 | 9 | |
| 17 | 23 | |
| 18 | 46 | |
| 19 | 1 | |
| 20 | 21 |
About Myriam Chalabi
Myriam Chalabi is a scholar working on Oncology, Pathology and Forensic Medicine and Cancer Research, having authored 38 papers that have together received 874 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (23 papers), Colorectal Cancer Treatments and Studies (17 papers) and Genetic factors in colorectal cancer (13 papers). The work is most often cited by research in Oncology (695 citations), Pathology and Forensic Medicine (217 citations) and Cancer Research (116 citations). Myriam Chalabi has collaborated with scholars based in Netherlands, United States and Belgium. Frequent co-authors include Marleen Kok, Monique E. van Leerdam, Andrés F. Cardona, Deepti R. Nagarkar, Fernanda Herrera, Achim Rittmeyer, Arianna Scala, Matthew L. Albert, David R. Gandara and Thomas Powles. Their work appears in journals such as Nature, Nature Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.